Clinical Knowledge Summary
Tirzepatide is studied for interaction with GLP-1 and GIP receptors in controlled laboratory environments
Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson DA, Deschenes MR, Maresh CM
During AOD 9604 and tirzepatide combination therapy, resistance training becomes even more important because the aggressive fat loss rate means the body will readily catabolize muscle if it is not receiving the stimulus to maintain it
It doesn't matter if you're a health professional, patient, or just someone who wants to know the product more thoroughly this article will provide useful information
Triple peptide research blend